Epilepsy, Temporal Lobe
33
10
10
12
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
1 terminated out of 33 trials
92.3%
+5.7% vs benchmark
6%
2 trials in Phase 3/4
17%
2 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 12 completed trials
Clinical Trials (33)
Investigating Epilepsy: Screening and Evaluation
Surgery as a Treatment for Medically Intractable Epilepsy
Studying Heart Rhythms With a Wearable Sensor to Detect and Predict Seizures in People With Epilepsy
Evaluation of the NaviFUS System in Drug Resistant Epilepsy
Spatial Scene Recognition Memory in Epilepsy Surgery
Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
A Pilot Study to Evaluate the Efficacy and Safety of NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy
Localizing Epileptic Networks Using MRI and iEEG
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)
Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy
Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients
Treating Deep Seizure Foci With Noninvasive Surface Brain Stimulation
Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus
Innovative MRI to Localize the Epileptic Zone
Low-intensity Focused Ultrasound Pulsation (LIFUP) for Treatment of Temporal Lobe Epilepsy
Epilepsy Surgery and Cognitive Outcome
A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
SEEG Guided RF-TC v.s. ATL for mTLE With HS
Self-modulation of the Sense of Agency by Means of Real-time Neurofeedback
EASINESS-TRIAL - Enhancing Safety in Epilepsy Surgery